Complex Measures and Indices for Clinical Research Compared with Simple Patient Questionnaires to Assess Function, Pain, and Global Estimates as Rheumatology "Vital Signs" for Usual Clinical Care

Rheumatic Disease Clinics of North America

Volumn 35, Issue 4, 2009, Pages 779-786

  Pincus, Theodore ^a   Bergman, Martin J ^b   Maclean, Ross ^c   Yazici, Yusuf ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Taylor Hospital   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Continuous quality improvement; Indices for rheumatic diseases; Questionnaires; Vital signs

Indexed keywords

ANAMNESIS; ANKYLOSING SPONDYLITIS; CLINICAL RESEARCH; FIBROMYALGIA; GOLD STANDARD; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LABORATORY TEST; MEDICAL DOCUMENTATION; OSTEOARTHRITIS; PATIENT MONITORING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; PSORIATIC ARTHRITIS; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

HEALTH STATUS INDICATORS; HUMANS; PAIN; QUESTIONNAIRES; RHEUMATIC DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 70749108713     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.10.010     Document Type: Review

References (63)

1. Goldsmith C.H., Smythe H.A., and Helewa A. Interpretation and power of pooled index. J Rheumatol 20 (1993) 575-578
2. van Riel P.L. Provisional guidelines for measuring disease activity in clinical trials on rheumatoid arthritis. [Editorial]. Br J Rheumatol 31 (1992) 793-794
3. Tugwell P., and Boers M. OMERACT Committee. Proceedings of the OMERACT conferences on outcome measures in rheumatoid arthritis clinical trials, Maastricht, Netherlands. J Rheumatol 20 (1993) 527-591
4. Felson D.T., Anderson J.J., Boers M., et al. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 36 (1993) 729-740
5. van der Heijde D.M., van't Hof M., van Riel P.L., et al. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 20 (1993) 579-581
6. Prevoo M.L., van't Hof M.A., Kuper H.H., et al. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38 (1995) 44-48
7. Aletaha D., and Smolen J. The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23 (2005) S100-S108
8. Pincus T., Bergman M.J., Yazici Y., et al. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology (Oxford) 47 (2008) 345-349
9. Pincus T., Swearingen C.J., Bergman M., et al. RAPID3 (routine assessment of patient index data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to DAS and CDAI categories. J Rheumatol 35 (2008) 2136-2147
10. Wolfe F., Michaud K., and Pincus T. A composite disease activity scale for clinical practice, observational studies and clinical trials: the patient activity scale (PAS/PAS-II). J Rheumatol 32 (2005) 2410-2415
11. Wells G.A., Boers M., Shea B., et al. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 32 (2005) 2016-2024
12. Sharp J.T., Lidsky M.D., Collins L.C., et al. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 14 (1971) 706-720
13. Sharp J.T. Scoring radiographic abnormalities in rheumatoid arthritis. J Rheumatol 16 (1989) 568-569
14. Sharp J.T. Assessment of radiographic abnormalities in rheumatoid arthritis: what have we accomplished and where should we go from here?. J Rheumatol 22 (1995) 1787-1791
15. van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 26 (1999) 743-745
16. Landewe R., and van der Heijde D. Radiographic progression in rheumatoid arthritis. Clin Exp Rheumatol 23 (2005) S63-S68
17. Larsen A. A radiological method for grading the severity of rheumatoid arthritis. [dissertation] (1974), University of Helsinki, Helsinki (Finland)
18. Larsen A., Dale K., and Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn (Stockh) 18 (1977) 481-491
19. Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in longterm studies?. J Rheumatol 22 (1995) 1974-1975
20. Rau R., Wassenberg S., Herborn G., et al. A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 25 (1998) 2094-2107
21. Clegg D.O., Reda D.J., Weisman M.H., et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 39 (1996) 2004-2012
22. Fleischer J.A.B., Feldman S.R., Rapp S.R., et al. Disease severity measures in a population of psoriasis patients: the symptoms of psoriasis correlate with self-administered psoriasis area severity index scores. J Invest Dermatol 107 (1996) 26-29
23. Hawker G., Gabriel S., Bombardier C., et al. A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. J Rheumatol 20 (1993) 657-660
24. Hay E.M., Bacon P.A., Gordon C., et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 86 (1993) 447-458
25. Swaak A.J., van den Brink H.G., Smeenk R.J., et al. Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation. Lupus 10 (2001) 51-58
26. Petri M., Hellmann D.B., and Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 19 (1992) 53-59
27. Mosca M., Bencivelli W., Vitali C., et al. The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus. Lupus 9 (2000) 445-450
28. Bencivelli W., Vitali C., Isenberg D.A., et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for rheumatology research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for disease activity in SLE. Clin Exp Rheumatol 10 (1992) 549-554
29. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 363-369
30. Gladman D.D., Urowitz M.B., Goldsmith C.H., et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 809-813
31. Calin A., Nakache J.P., Gueguen A., et al. Defining disease activity in ankylosing spondylitis: is a combination of variables (bath ankylosing spondylitis disease activity index) an appropriate instrument?. Rheumatology (Oxford) 38 (1999) 878-882
32. Creemers M.C., Franssen M.J., van't Hof M.A., et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 64 (2005) 127-129
33. Calin A., MacKay K., Santos H., et al. A new dimension to outcome: application of the bath ankylosing spondylitis radiology index. J Rheumatol 26 (1999) 988-992
34. Calin A., Garrett S., Whitelock H., et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the bath ankylosing spondylitis functional index. J Rheumatol 21 (1994) 2281-2285
35. Jenkinson T.R., Mallorie P.A., Whitelock H.C., et al. Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS metrology index. J Rheumatol 21 (1994) 1694-1698
36. Dougados M., Gueguen A., Nakache J.P., et al. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 15 (1988) 302-307
37. Luqmani R.A., Bacon P.A., Moots R.J., et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 87 (1994) 671-678
38. Whiting O'Keefe Q.E., Stone J.H., and Hellmann D.B. Validity of a vasculitis activity index for systemic necrotizing vasculitis. Arthritis Rheum 42 (1999) 2365-2371
39. Stone J.H., Hoffman G.S., Merkel P.A., et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham vasculitis activity score. Arthritis Rheum 44 (2001) 912-920
40. Exley A.R., Bacon P.A., Luqmani R.A., et al. Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40 (1997) 371-380
41. Seo P., Min Y., Holbrook J.T., et al. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trail (WGET). Arthritis Rheum 52 (2005) 2168-2178
42. Bellamy N., Buchanan W.W., Goldsmith C.H., et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15 (1988) 1833-1840
43. Burckhardt C.S., Clark S.R., and Bennett R.M. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18 (1991) 728-733
44. Fries J.F., Spitz P., Kraines R.G., et al. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980) 137-145
45. Wolfe F., Michaud K., and Pincus T. Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 50 (2004) 3296-3305
46. Pincus T., Swearingen C., and Wolfe F. Toward a multidimensional health assessment questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient friendly health assessment questionnaire format. Arthritis Rheum 42 (1999) 2220-2230
47. Pincus T., Sokka T., and Kautiainen H. Further development of a physical function scale on a multidimensional health assessment questionnaire for standard care of patients with rheumatic diseases. J Rheumatol 32 (2005) 1432-1439
48. Tugwell P., and Bombardier C. A methodologic framework for developing and selecting endpoints in clinical trials. J Rheumatol 9 (1982) 758-762
49. Bombardier C., and Tugwell P. A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. J Rheumatol 9 (1982) 753-757
50. Pincus T., Yazici Y., and Bergman M. Development of a multi-dimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care. Clin Exp Rheumatol 23 (2005) S19-S28
51. Pincus T., and Wolfe F. Patient questionnaires for clinical research and improved standard patient care: is it better to have 80% of the information in 100% of patients or 100% of the information in 5% of patients?. J Rheumatol 32 (2005) 575-577
52. Pincus T., Yazici Y., and Bergman M. Saving time and improving care with a multidimensional health assessment questionnaire: 10 practical considerations. J Rheumatol 33 (2006) 448-454
53. Pincus T., Yazici Y., and Bergman M. A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or computers. Best Pract Res Clin Rheumatol 21 (2007) 755-787
54. Pincus T., Yazici Y., and Sokka T. Quantitative measures of rheumatic diseases for clinical research versus standard clinical care: differences, advantages and limitations. Best Pract Res Clin Rheumatol 21 (2007) 601-628
55. Yazici Y., Bergman M., and Pincus T. Time to score quantitative rheumatoid arthritis measures: 28-joint count, disease activity score, health assessment questionnaire (HAQ), multidimensional HAQ (MDHAQ), and routine assessment of patient index data (RAPID) scores. J Rheumatol 35 (2008) 603-609
56. Pincus T, Swearingen CJ, Bergman MJ, et al. RAPID3 on an MDHAQ is correlated significantly with activity levels of DAS28 and CDAI, but scored in 5 versus more than 90 seconds. Arthritis Care Res, in press.
57. Fuchs H.A., Brooks R.H., Callahan L.F., et al. A simplified twenty-eight joint quantitative articular index in rheumatoid arthritis. Arthritis Rheum 32 (1989) 531-537
58. Pincus T., and Wolfe F. An infrastructure of patient questionnaires at each rheumatology visit: improving efficiency and documenting care. J Rheumatol 27 (2000) 2727-2730
59. Wolfe F., and Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum 42 (1999) 1797-1808
60. Bergmann F.J., Chassany O., Gandiol J., et al. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal 29 (1994) 41-47
61. Pincus T. Pain, function, and RAPID scores-vital signs in chronic diseases, analogous to pulse and temperature in acute diseases and blood pressure and cholesterol in long-term health. Bull NYU Hosp Jt Dis 66 (2008) 155-165
62. Wolfe F., Pincus T., Thompson A.K., et al. The assessment of rheumatoid arthritis and the acceptability of self-report questionnaires in clinical practice. Arthritis Care Res 49 (2003) 59-63
63. Russak S.M., Croft Jr. J.D., Furst D.E., et al. The use of rheumatoid arthritis health-related quality of life patient questionnaire in clinical practice: lessons learned. Arthritis Rheum 49 (2003) 574-584